WRBC
SCMP

W.R. Berkley Corp’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

W.R. Berkley Corp’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-99,028
Closed -$1.78M – 125
2017
Q4 		$1.78M Buy
+99,028
New +$1.22M 0.19% 65

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

W.R. Berkley Corp's SCMP Position: Q1 2018 in Review

W.R. Berkley Corp sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 99,028 shares — an estimated $1.78M sold.

W.R. Berkley Corp first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $1.78M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • W.R. Berkley Corp reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • W.R. Berkley Corp sold 99,028 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.78M.
  • W.R. Berkley Corp first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • W.R. Berkley Corp's Sucampo Pharmaceuticals, Inc. position peaked at $1.78M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on W.R. Berkley Corp's 13F filing for Q1 2018, filed 15 May 2018.